https://tissuepathology.com Educational and informative Fri, 17 Jul 2026 11:38:08 +0000 en-US hourly 1 https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png https://tissuepathology.com 32 32 https://tissuepathology.com/2026/07/17/techcyte-fusion-anatomic-pathology-advances-digital-pathology-transformation-at-mayo-clinic/ Fri, 17 Jul 2026 11:38:08 +0000 https://tissuepathology.com/?p=24559 Techcyte and Mayo Clinic: Deployment across Mayo Clinic pathology practices integrates AI-enabled digital pathology with historical pathology images and clinical data in a unified workflow. Mayo Clinic and Techcyte today announced the implementation of Anatomic Pathology (AP) technology, a next-generation digital pathology platform developed through a co-development and intellectual property licensing agreement between the two […]

The post Techcyte Fusion® Anatomic Pathology advances digital pathology transformation at Mayo Clinic first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/07/14/techcyte-announces-go-live-of-fusion-parasitology-suite-at-sonora-quest-laboratories/ Tue, 14 Jul 2026 12:12:09 +0000 https://tissuepathology.com/?p=24551 OREM, UT, UNITED STATES, July 13, 2026 /EINPresswire.com/ — Techcyte today announced that Sonora Quest Laboratories, one of the largest integrated laboratory systems in the United States, has gone live with the Techcyte Fusion® Parasitology Suite (for research use only). As a joint venture between Banner Health and Quest Diagnostics, Sonora Quest Laboratories plays a key role in delivering […]

The post Techcyte Announces Go-Live of Fusion Parasitology Suite at Sonora Quest Laboratories first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/07/10/lumito-and-navinci-initiate-pilot-project-promising-initial-results-from-evaluation-of-combined-technology/ Fri, 10 Jul 2026 12:29:58 +0000 https://tissuepathology.com/?p=24545 July 9, 2026 – Lumito AB (publ) (“Lumito” or the “Company”) today announces that the Company has initiated a pilot project together with the Swedish biotech company Navinci Diagnostics AB (”Navinci”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis […]

The post Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/07/08/agenus-and-noetik-present-asco-2026-data-linking-ai-analysis-of-routine-pretreatment-tumor-pathology-images-to-response-and-survival-with-botbal-in-mss-metastatic-crc/ Wed, 08 Jul 2026 12:15:19 +0000 https://tissuepathology.com/?p=24536 Agenus and Noetik: Noetik’s TARIO-2 platform analyzed routine pretreatment H&E images from 113 BOT+BAL-treated patients and identified spatial tumor microenvironment patterns associated with response and survival In a retrospective analysis of refractory MSS metastatic colorectal cancer without active liver metastases, the AI-identified subgroup had a 64% response rate to BOT+BAL, compared with 9% in the […]

The post Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/07/06/tempus-announces-research-collaboration-with-angiosarcoma-awareness-inc-to-uncover-insights-on-rare-cancers/ Mon, 06 Jul 2026 12:12:01 +0000 https://tissuepathology.com/?p=24532 CHICAGO, June 25, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a research collaboration with Angiosarcoma Awareness, Inc. to accelerate data-driven research in angiosarcoma, one of the rarest and most aggressive cancers. Angiosarcoma is a rare malignant tumor that starts […]

The post Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers first appeared on Tissuepathology.com.]]> https://tissuepathology.com/2026/06/30/bioptimus-partnership-with-french-cancer-research-network-ffcd-expands-bioptimuss-stela-programme/ Tue, 30 Jun 2026 13:05:31 +0000 https://tissuepathology.com/?p=24520 Partnership grants Bioptimus access to unique European cohort of data Fédération Francophone de Cancérologie Digestive to share high quality clinical data of 3,000 GI cancer patients Significant progress in the STELA programme to build the largest global AI biology model More partnership announcements in Bioptimus’s pipeline Tuesday June 27th 2026 – Paris, France: Bioptimus has […]

The post Bioptimus: Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme first appeared on Tissuepathology.com.]]>